Analyst Comment Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon VK2735 could potentially become a direct competitor to Eli Lilly's Mounjaro. GlobalData Healthcare
Analyst Comment Obicetrapib holds potential to become first CETP inhibitor to advance to clinical practice
Analyst Comment US study explores racial disparities in the treatment of type 2 diabetes GlobalData Healthcare
Analyst Comment Spinal muscular atrophy market to reach $3bn across 7MM by 2033 GlobalData Healthcare
Analyst Comment Battling bacterial behemoths: The AMR and MRSA challenge GlobalData Thematic Intelligence
Analyst Comment Tampons containing arsenic and lead pose significant health risks GlobalData Healthcare
Analyst Comment Anxiety identified as major indicator of Parkinson’s disease in older adults GlobalData Healthcare
Analyst Comment EAN 2024: Opicapone demonstrates efficacy in real-world clinical practice GlobalData Healthcare
Analyst Comment EAN 2024: The role of B cells in shaping rituximab use in generalised MG GlobalData Healthcare
Analyst Comment EAN 2024: Benefits of early migraine treatment clear but implementation remains challenging GlobalData Healthcare
Analyst Comment Female infertility market expected to reach $2.3bn across the 7MM by 2033 GlobalData Healthcare
Analyst Comment EAN 2024: VNS and cenobamate – a new therapeutic alliance for drug-resistant epilepsy? GlobalData Healthcare
Analyst Comment EAN 2024: Treatment cessation and reinitiation can reduce benefits of Ajovy GlobalData Healthcare
Analyst Comment EAN 2024: encouraging analyses of pridopidine Healey ALS platform trial GlobalData Healthcare
Analyst Comment CAR T cells in lupus: Promising results at EULAR 2024 and emergence of China GlobalData Healthcare
Analyst Comment FDA go-ahead for Verona Ohtuvayre transforms US COPD exacerbator market GlobalData Healthcare
Analyst Comment Are clinical trial sites unfairly bearing the brunt of trial failures? GlobalData Healthcare
Analyst Comment Heatwave increases risk of serious cardiovascular health problems GlobalData Healthcare
Analyst Comment Capvaxive will enhance protection against pneumococcal disease in older adults GlobalData Healthcare
Analyst Comment Chronic kidney disease market estimated to grow at 19.6%, driven by pipeline agents aimed at unmet needs GlobalData Healthcare
Analyst Comment Gay and bisexual men have higher risk of anxiety and depression GlobalData Healthcare
Analyst Comment Covid-19 increases cardiovascular event risk in chronic respiratory patients GlobalData Healthcare
Analyst Comment EHA 2024: Brukinsa/Venclexta for CLL/SLL lacks control arm in SEQUOIA trial GlobalData Healthcare
Analyst Comment Beacon Therapeutics treats first patient with AGTC-501 in pivotal VISTA trial GlobalData Healthcare
Analyst Comment EHA 2024: Odronextamab shows promise in ELM-2 study for follicular lymphoma GlobalData Healthcare